RELIEF THERAPEUTICS HOLDING
RELIEF THERAPEUTICS HOLDING/ CH1251125998 /
RLF/Z
|
4/2/2024 4:55:05 PM
|
Chg.
-0.08
|
Volume |
Bid- |
Ask- |
Market Capitalization |
Dividend Y. |
P/E Ratio |
|
1.29CHF
|
-5.51%
|
167
Turnover: 216.46 |
-Bid Size: - |
-Ask Size: - |
33.14 mill.CHF |
- |
- |
Fundamentals
| |
FY 2023 |
Growth (1Y) |
| Per Share |
|
| Earnings per Share: |
-6.99 EUR |
45.63% |
| EPS Diluted: |
- EUR |
45.63% |
| Revenues per Share: |
0.43 EUR |
-62.29% |
| Book Value per Share: |
3.72 EUR |
-64.08% |
| Cash Flow per Share: |
-1.25 EUR |
-27.00% |
| Dividend per Share: |
- EUR |
- |
| Total |
in mill. |
|
| Revenues: |
6.03 EUR |
-62.29% |
| Net Income: |
-98.18 EUR |
93.31% |
| Operating Cash Flow: |
-17.61 EUR |
- |
| Cash and Cash Equivalents: |
14.56 EUR |
- |
Valuation Ratios
| |
Current |
Latest FY* |
| P/E Ratio: |
- |
- |
| P/S Ratio: |
5.87 |
4.63 |
| P/BV ratio: |
0.68 |
0.54 |
| P/CF Ratio: |
-2.01 |
-1.59 |
| PEG: |
-0.01 |
- |
| Earnings Yield: |
-277.17% |
-351.26% |
| Dividend Yield: |
- |
- |
| Market Capitalization |
|
| Market Capitalization: |
33.14 mill. CHF |
25.87 mill. CHF |
| Free Float Market Cap.: |
- CHF |
- CHF |
| Market Cap. / Employee: |
- CHF |
- CHF |
| Shares Outstanding: |
14.04 mill. |
|
Profitability
| Gross Profit Margin: |
71.22% |
| EBIT Margin: |
-1,837.03% |
| Net Profit Margin: |
-1,627.40% |
| Return on Equity: |
-187.99% |
| Return on Assets: |
-128.53% |
Financial Strength
| Liquidity I / Cash Ratio: |
210.68% |
| Liquidity II / Quick Ratio: |
227.63% |
| Liquidity III / Current Ratio: |
264.93% |
| Debt / Equity Ratio: |
46.26% |
| Dynam. Debt / Equity Ratio: |
-137.19% |
Efficiency
| Employees: |
- |
| Personal Expenses / Employee: |
- EUR |
| Revenues / Employee: |
- EUR |
| Net Income / Employee: |
- EUR |
| Total Assets / Employee: |
- EUR |
| * Fiscal Year End: |
12/31/2023 |
| Accounting Standard: |
IFRS |
